Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexual and Gender Minorities | 7 | 2023 | 192 | 2.800 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 7 | 2022 | 212 | 2.610 |
Why?
|
| Hepatitis B | 3 | 2022 | 74 | 1.960 |
Why?
|
| Liver Transplantation | 9 | 2023 | 1267 | 1.680 |
Why?
|
| Gastroenterology | 6 | 2023 | 134 | 1.520 |
Why?
|
| Hepatitis B, Chronic | 3 | 2017 | 32 | 1.290 |
Why?
|
| Virus Activation | 3 | 2017 | 41 | 1.280 |
Why?
|
| Hepatitis B virus | 4 | 2022 | 43 | 1.060 |
Why?
|
| End Stage Liver Disease | 5 | 2023 | 61 | 0.990 |
Why?
|
| Antiviral Agents | 6 | 2022 | 510 | 0.980 |
Why?
|
| Women's Rights | 1 | 2024 | 7 | 0.970 |
Why?
|
| Kidney Failure, Chronic | 2 | 2019 | 509 | 0.960 |
Why?
|
| Hepatitis C, Chronic | 3 | 2019 | 126 | 0.950 |
Why?
|
| Hepatitis A | 1 | 2022 | 4 | 0.860 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2022 | 25 | 0.850 |
Why?
|
| Kidney Transplantation | 2 | 2019 | 849 | 0.850 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 4 | 2023 | 40 | 0.840 |
Why?
|
| Donor Selection | 2 | 2019 | 67 | 0.810 |
Why?
|
| Abortion, Induced | 1 | 2024 | 120 | 0.800 |
Why?
|
| Transplant Recipients | 2 | 2019 | 122 | 0.770 |
Why?
|
| Nephrology | 1 | 2019 | 45 | 0.680 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 370 | 0.670 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2017 | 24 | 0.620 |
Why?
|
| Hepatitis B Antibodies | 1 | 2017 | 15 | 0.620 |
Why?
|
| Attitude to Health | 1 | 2018 | 220 | 0.600 |
Why?
|
| Transgender Persons | 3 | 2024 | 95 | 0.600 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2021 | 549 | 0.590 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2019 | 383 | 0.570 |
Why?
|
| Guanine | 1 | 2017 | 208 | 0.570 |
Why?
|
| Hepatitis C | 1 | 2018 | 208 | 0.560 |
Why?
|
| Tissue and Organ Procurement | 2 | 2019 | 311 | 0.550 |
Why?
|
| Humans | 38 | 2024 | 86601 | 0.550 |
Why?
|
| Gastroenterologists | 1 | 2016 | 30 | 0.540 |
Why?
|
| Graft Rejection | 3 | 2019 | 1065 | 0.500 |
Why?
|
| Hepatitis | 1 | 2014 | 35 | 0.500 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2014 | 29 | 0.500 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 735 | 0.490 |
Why?
|
| Guideline Adherence | 1 | 2016 | 223 | 0.490 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 636 | 0.490 |
Why?
|
| Liver Function Tests | 1 | 2014 | 93 | 0.480 |
Why?
|
| Uvula | 1 | 2013 | 6 | 0.470 |
Why?
|
| Gastroscopy | 1 | 2013 | 23 | 0.470 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 329 | 0.470 |
Why?
|
| Neoplasms | 3 | 2018 | 2897 | 0.460 |
Why?
|
| Transsexualism | 2 | 2024 | 34 | 0.450 |
Why?
|
| Fatty Liver | 1 | 2014 | 124 | 0.440 |
Why?
|
| Liver Diseases | 3 | 2023 | 238 | 0.420 |
Why?
|
| Deglutition Disorders | 1 | 2013 | 115 | 0.420 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1034 | 0.400 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 336 | 0.390 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 977 | 0.380 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 581 | 0.380 |
Why?
|
| Female | 18 | 2024 | 44507 | 0.370 |
Why?
|
| Liver Cirrhosis | 5 | 2023 | 297 | 0.360 |
Why?
|
| Gender Identity | 3 | 2024 | 52 | 0.340 |
Why?
|
| Adult | 15 | 2023 | 25640 | 0.330 |
Why?
|
| United States | 7 | 2023 | 6665 | 0.320 |
Why?
|
| Waiting Lists | 2 | 2019 | 175 | 0.310 |
Why?
|
| Risk Factors | 5 | 2022 | 5416 | 0.290 |
Why?
|
| Gastrointestinal Tract | 3 | 2023 | 191 | 0.290 |
Why?
|
| Mass Screening | 3 | 2018 | 617 | 0.290 |
Why?
|
| Sexual Behavior | 3 | 2023 | 302 | 0.280 |
Why?
|
| Tissue Donors | 2 | 2019 | 463 | 0.280 |
Why?
|
| Liver | 3 | 2019 | 1229 | 0.260 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 2501 | 0.260 |
Why?
|
| Male | 12 | 2023 | 40956 | 0.250 |
Why?
|
| Hepacivirus | 3 | 2019 | 159 | 0.240 |
Why?
|
| Lactulose | 1 | 2023 | 19 | 0.240 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 806 | 0.240 |
Why?
|
| Digestive System Diseases | 1 | 2023 | 18 | 0.230 |
Why?
|
| Hepatic Encephalopathy | 1 | 2023 | 40 | 0.230 |
Why?
|
| Age Factors | 2 | 2018 | 1849 | 0.220 |
Why?
|
| Pregnancy | 2 | 2024 | 2893 | 0.220 |
Why?
|
| Middle Aged | 9 | 2021 | 25017 | 0.220 |
Why?
|
| Stomach | 1 | 2023 | 108 | 0.210 |
Why?
|
| Quality of Life | 2 | 2021 | 1583 | 0.210 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2021 | 33 | 0.210 |
Why?
|
| Culturally Competent Care | 1 | 2021 | 12 | 0.200 |
Why?
|
| Ascites | 1 | 2021 | 55 | 0.200 |
Why?
|
| Retrospective Studies | 9 | 2023 | 8475 | 0.200 |
Why?
|
| Allografts | 2 | 2019 | 172 | 0.200 |
Why?
|
| Aged | 7 | 2021 | 18402 | 0.200 |
Why?
|
| Personal Satisfaction | 1 | 2021 | 62 | 0.190 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2020 | 19 | 0.190 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2020 | 24 | 0.190 |
Why?
|
| Treatment Outcome | 7 | 2023 | 7988 | 0.190 |
Why?
|
| Graft Survival | 5 | 2022 | 884 | 0.180 |
Why?
|
| Racism | 1 | 2021 | 81 | 0.180 |
Why?
|
| Severity of Illness Index | 5 | 2023 | 1801 | 0.170 |
Why?
|
| Cohort Effect | 1 | 2019 | 6 | 0.170 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 229 | 0.170 |
Why?
|
| Canada | 1 | 2019 | 204 | 0.170 |
Why?
|
| Viremia | 1 | 2019 | 54 | 0.170 |
Why?
|
| Registries | 2 | 2019 | 702 | 0.160 |
Why?
|
| Fear | 1 | 2018 | 78 | 0.160 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 394 | 0.160 |
Why?
|
| Nursing Diagnosis | 1 | 2017 | 1 | 0.160 |
Why?
|
| Internal Medicine | 1 | 2021 | 347 | 0.150 |
Why?
|
| Dyslipidemias | 1 | 2018 | 109 | 0.150 |
Why?
|
| Urban Population | 1 | 2018 | 213 | 0.150 |
Why?
|
| Weight Loss | 1 | 2018 | 229 | 0.150 |
Why?
|
| Prevalence | 1 | 2021 | 1239 | 0.150 |
Why?
|
| Curriculum | 1 | 2021 | 539 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2021 | 418 | 0.150 |
Why?
|
| Rheumatologists | 1 | 2016 | 6 | 0.140 |
Why?
|
| Dermatologists | 1 | 2016 | 2 | 0.140 |
Why?
|
| Incidence | 2 | 2019 | 1576 | 0.140 |
Why?
|
| Students, Medical | 1 | 2021 | 384 | 0.140 |
Why?
|
| Rheumatic Diseases | 1 | 2016 | 20 | 0.140 |
Why?
|
| Oncologists | 1 | 2016 | 36 | 0.140 |
Why?
|
| Rituximab | 1 | 2016 | 116 | 0.130 |
Why?
|
| Sex Factors | 1 | 2018 | 1054 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 508 | 0.130 |
Why?
|
| Cholagogues and Choleretics | 1 | 2014 | 10 | 0.130 |
Why?
|
| Folic Acid Antagonists | 1 | 2014 | 19 | 0.130 |
Why?
|
| Colchicine | 1 | 2014 | 23 | 0.130 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2014 | 23 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 378 | 0.130 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 24 | 0.130 |
Why?
|
| Chicago | 1 | 2018 | 1379 | 0.120 |
Why?
|
| Hypertension | 1 | 2023 | 1141 | 0.120 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2014 | 70 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 392 | 0.120 |
Why?
|
| Frozen Sections | 1 | 2014 | 48 | 0.120 |
Why?
|
| Methotrexate | 1 | 2014 | 249 | 0.120 |
Why?
|
| Kidney | 1 | 2019 | 1241 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2019 | 2261 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 999 | 0.110 |
Why?
|
| Heart Failure | 1 | 2023 | 1203 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2019 | 2767 | 0.110 |
Why?
|
| Necrosis | 1 | 2013 | 204 | 0.110 |
Why?
|
| Psoriasis | 1 | 2016 | 240 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2019 | 4210 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 683 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2021 | 1004 | 0.100 |
Why?
|
| Biopsy | 1 | 2014 | 1161 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1565 | 0.090 |
Why?
|
| Prognosis | 1 | 2017 | 3674 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1673 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 2436 | 0.070 |
Why?
|
| Patient Selection | 2 | 2021 | 685 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 860 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2357 | 0.060 |
Why?
|
| Digestion | 1 | 2023 | 7 | 0.060 |
Why?
|
| Atrial Pressure | 1 | 2023 | 6 | 0.060 |
Why?
|
| Platelet Count | 1 | 2023 | 92 | 0.060 |
Why?
|
| Minority Health | 1 | 2021 | 10 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 78 | 0.050 |
Why?
|
| Career Choice | 1 | 2021 | 139 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2021 | 225 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2024 | 426 | 0.040 |
Why?
|
| Stents | 1 | 2021 | 377 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 746 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 351 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2019 | 166 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 454 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 572 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 857 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 3611 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2021 | 751 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1860 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3636 | 0.030 |
Why?
|
| Mice | 1 | 2023 | 11352 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5974 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 26581 | 0.020 |
Why?
|